# GRAM NEGATIVES STUDY

> **NCT07749508** · — · RECRUITING · sponsor: **Fundacion SEIMC-GESIDA** · enrollment: 1500 (estimated)

## Conditions studied

- Multi-resistant Gram-negative Bacteria Cause Infection

## Interventions

- **DRUG:** Standard of care therapy

## Key facts

- **NCT ID:** NCT07749508
- **Lead sponsor:** Fundacion SEIMC-GESIDA
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749508, "GRAM NEGATIVES STUDY". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07749508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*